STRESAM® (ETIFOXINE)

Chemical name Etifoxine / Etafenoxine Form: 24 pills of 50mg / 60 pills of 50mg Form description: Smooth, shiny gelatin capsules with a white body and a blue cap; the content is a powder of white or white with a slight yellowish tint. Active ingredient: Etifoxine hydrochloride, 50 mg Excipients: Lactose monohydrate, Talc, Microcrystalline cellulose, Anhydrous colloidal silicon dioxide, and Magnesium stearate. Capsule shell composition: titanium dioxide, gelatin, indigo carmine. СAS Number: 21715-46-8 ATC code: N05BX03 Pharmacological action: Anxiolytic (tranquilizer) Bioavailability: 90% Shelf life: 3 years. Do not use it beyond the expiration date printed on the package. Storage conditions: Store at temperatures of 15-25°C (59-77°F). Keep out of reach of children. Terms of release: Over-the-counter Manufacturer: Biocodex, France Stresam (Etifoxine) is an anxiolytic and anticonvulsant compound. Its active ingredient, etifoxine, is a benzoxazine derivative known for its selectivity and physiological mode of action. Etifoxine stimulates the production of neurosteroids in the brain, which can indirectly modulate GABAergic activity. Stresam is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. In the United States, etifoxine is primarily used as a research chemical in pharmaceutical studies. However, it is approved for medical use in more than 40 countries. For more details, please refer to the manufacturer’s instructions or peer-reviewed scientific literature. Note: In accordance with FDA regulations, we do not provide information regarding medical indications or therapeutic uses of this compound on our website.